Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mivacurium Chloride vs Succinylcholine for Bronchoscopy
NCT06709066Not yet recruiting
- Start
- Nov 2024
- Primary completion
- Dec 2025
- Modality
- Small Molecules
01
Overview
Randomised trial of mivacurium (2 arms). Primary endpoint: Rate of spontaneous breathing recovery at 15 months. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
mivacurium
Beyond the preview
Go deeper on NCT06709066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06709066.